Full-Time

Senior Scientist II

Computational Discovery Science

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

$130k - $175kAnnually

+ Incentive Compensation + Restricted Stock Units

Senior

Company Historically Provides H1B Sponsorship

Chicago, IL, USA

This is a hybrid position, which may require some in-office days.

Category
Computational Biology
Genomics
Public Health
Biology & Biotech
Required Skills
Python
R
SQL

You match the following Tempus's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • PhD degree in a quantitative discipline (e.g., Biostatistics/Statistical Genetics, Bioinformatics, Computational Biology, Computational Immunology, or similar) plus 2 years of experience or postdoctoral studies
  • Alternatively, a PhD in Molecular Biology or another Life Science degree combined with a very strong record of computational biology
  • Minimum 2+ years in drug development leveraging genomic and clinical/real-world data for drug discovery and development
  • Proficient in R, Python, and SQL
  • Strong understanding of cancer biology
  • Excellent written and verbal communication skills, with the ability to present complex information clearly and persuasively to diverse audiences
Responsibilities
  • Partner with our pharma clients to design, develop, and execute computational target discovery research projects leveraging the Tempus platform to advance precision medicine research programs
  • Develop and implement scientific strategies and experimental work plans, including identifying new methodologies and approaches for large clinico-genomic databases and PDOs
  • Integrate the above to prioritize target opportunities matched to biomarker and indication strategies that enhance the likelihood of developmental success
  • Evaluate clinical trial design by testing assumptions, refining eligibility criteria, and characterizing patient outcomes on standard of care
  • Develop novel biomarkers of response signatures
  • Independently execute complex translational or real-world evidence research projects integrating molecular and clinical data from Tempus’ multimodal data platform to derive real-world insights for biopharma partners
  • Expert in navigating client interactions; present scientific findings clearly and meaningfully to diverse sets of external stakeholders
  • Document, summarize, and communicate highly technical results and methods clearly to non-technical audiences
  • Author abstracts, posters, and peer-reviewed publications to illustrate the value of multimodal analysis and AI in drug discovery in coordination with our partners or internal R&D teams
  • Become an expert in our biopharma partners’ strategy, pipeline, and portfolio to proactively determine all areas that the Tempus platform could add value to the drug development process of our partners
  • Stay current with industry trends, best practices, and advancements in computational oncology research. Apply this knowledge to enhance research methodologies and improve overall research quality on the team.
Desired Qualifications
  • Strong understanding of statistical methods, molecular data, and machine learning in drug discovery with experience in integrative modeling of multi-modal clinical and omics data
  • Previous experience working with large transcriptome and NGS data sets
  • Prior consulting and/or client-facing experience is highly desirable
  • Ability to work collaboratively in a team environment
  • Thrive in a fast-paced environment and willing to shift priorities seamlessly
  • Experience with R package development
  • Strong peer-reviewed publication record
  • Experience with: Pandas, NumPy, SciPy, Scikit-learn, Jupyter Notebooks, RStudio, tidyverse, ggplot, Git, matplotlib, seaborn
  • Goal orientation, self-motivation, and drive to make a positive impact in healthcare

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data to assist physicians in making informed treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights, aiming to improve patient care and support drug development.

Company Stage

IPO

Total Funding

$894.9M

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • AI integration in EHR systems supports Tempus' data analytics capabilities.
  • Growing demand for personalized medicine boosts Tempus' therapy solutions.
  • AI-powered health apps market growth supports Tempus' olivia app success.

What critics are saying

  • Ambry Genetics acquisition may strain Tempus' financial resources and integration efforts.
  • xT CDx test faces competition, impacting market penetration and revenue.
  • olivia app may raise privacy concerns, affecting user adoption and trust.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform offers personalized therapy options, enhancing patient care and drug development.
  • Tempus' pan-cancer organoid platform and liquid biopsy assay are unique in cancer research.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Relocation Assistance

Company Equity

Performance Bonus